Catheter Related Bloodstream Infection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type, By Source of Infection, By Distribution Channel, By Region and Competition, 2020-2030F

Description

Global Catheter Related Bloodstream Infection Market was valued at USD 1.62 Billion in 2024 and is expected to reach USD 2.25 Billion by 2030 with a CAGR of 5.62% during the forecast period. The global Catheter Related Bloodstream Infection market is primarily driven by the increasing prevalence of hospital-acquired infections, particularly those associated with central venous catheters. Catheter related bloodstream infections are among the most frequent and serious complications of central venous catheter use, leading to significant morbidity, mortality, and healthcare costs. The rising incidence of bloodstream infections, especially in high-risk groups like immunocompromised patients undergoing treatments such as chemotherapy, further fuels market growth. The growing concern over antibiotic resistance, which complicates the treatment of catheter related bloodstream infections, has led to a rising demand for advanced diagnostic tools and infection prevention strategies. These combined factors are contributing to the expansion of the global Catheter Related Bloodstream Infection market.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1.62 Billion
Market Size 2030	USD 2.25 Billion
CAGR 2025-2030	5.62%
Fastest Growing Segment	Anti-microbial Agents
Largest Market	North America

Key Market Drivers

Increasing Prevalence of Hospital-Acquired Infections

Hospital-acquired infections (HAIs) are one of the most significant health concerns in medical settings globally. Catheter-related bloodstream infections (CRBSIs) are one of the leading types of HAIs, and their rising prevalence plays a substantial role in driving the growth of the global Catheter Related Bloodstream Infection market. These infections occur when pathogens enter the bloodstream through central venous catheters, a common medical device used for administering medications, fluids, and nutrients to critically ill patients. The growing number of patients requiring invasive procedures such as surgeries, dialysis, and long-term intravenous treatments leads to an increase in catheter usage, thus elevating the risk of CRBSIs. This, in turn, results in an increased demand for effective infection prevention and diagnostic solutions. According to WHO, On average, approximately 1 in 10 patients experiences healthcare-associated infections (HAIs); however, the incidence is notably higher in low- and middle-income countries, as well as among high-risk patients, such as those in intensive care units. According to a 2023 study by Balasubramanian et al., around 136 million cases of healthcare-associated antibiotic-resistant infections occur globally each year. In Europe, the impact of the six most common HAIs was found to be twice as significant as the combined burden of 32 other infectious diseases, in terms of disability and premature mortality. Additionally, it was estimated that 63.5% of infections caused by antibiotic-resistant bacteria are associated with healthcare settings.

Key Market Challenges

High Cost of Advanced Infection Prevention Technologies

One of the significant challenges in the global Catheter Related Bloodstream Infection market is the high cost of advanced infection prevention technologies. While innovative solutions such as antimicrobial-coated catheters, rapid diagnostic tools, and biofilm-resistant materials have proven effective in reducing infection rates, these technologies often come with a premium price. This cost barrier can be a challenge, especially in low-resource healthcare settings or emerging markets where budget constraints are a significant concern. Hospitals and healthcare providers may be hesitant to adopt these advanced solutions if they face financial limitations, despite the long-term benefits in terms of improved patient outcomes and reduced healthcare costs. The cost of training healthcare staff to effectively use these advanced technologies and maintain infection control protocols further compounds the financial burden on healthcare systems, making it difficult for some institutions to fully embrace these innovations.

Key Market Trends

Technological Advancements in Catheter Materials

Innovations in catheter design and material science are also contributing to the growth of the catheter-related bloodstream infection market. One significant development has been the introduction of antimicrobial-coated catheters, which are designed to reduce the risk of infection by inhibiting the growth of bacteria and other pathogens on the surface of the catheter. These catheters have been shown to significantly decrease the incidence of catheter-related bloodstream infections, especially in high-risk patient populations. In January 2025, Autonomix Medical, Inc. announced that it has achieved "design lock" for its Application Specific Integrated Circuits (ASIC) microchip. This milestone follows the successful completion of in vivo preclinical testing and extensive bench testing, marking continued progress toward the Company's U.S. pivotal trial.

The development of biofilm-resistant materials, which prevent the formation of bacterial biofilms on catheter surfaces, is further enhancing the safety and efficacy of catheters. As these technologies continue to advance, the demand for these more sophisticated catheter products is likely to grow, driving market expansion.

Key Market Players

Teva Pharmaceutical Industries Ltd.
SteriMax Inc.
Sanofi S.A.
Pfizer Inc.
Novartis AG
Merck & Co., Inc.
GSK plc
Fresenius SE & Co. KGaA
Eli Lilly and Company
Aurobindo Pharma Limited

Report Scope:

In this report, the Global Catheter Related Bloodstream Infection Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Catheter Related Bloodstream Infection Market, By Treatment Type:

Anti-microbial Agents
Antibiotic Lock Therapy

Catheter Related Bloodstream Infection Market, By Source of Infection:

Coagulase-negative Staphylococcus
S. Aureus
Enteric Gram-negative Bacilli
Yeasts
Enterococci & Streptococci
Pseudomonas
Others

Catheter Related Bloodstream Infection Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Catheter Related Bloodstream Infection Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Catheter Related Bloodstream Infection Market.

Available Customizations:

Global Catheter Related Bloodstream Infection market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Catheter Related Bloodstream Infection Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Treatment Type (Anti-microbial Agents and Antibiotic Lock Therapy)
- 5.2.2. By Source of Infection (Coagulase-negative Staphylococcus, S. Aureus, Enteric Gram-negative Bacilli, Yeasts, Enterococci & Streptococci, Pseudomonas, and Others)
- 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Catheter Related Bloodstream Infection Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Treatment Type
- 6.2.2. By Source of Infection
- 6.2.3. By Distribution Channel
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Catheter Related Bloodstream Infection Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Treatment Type
    - 6.3.1.2.2. By Source of Infection
    - 6.3.1.2.3. By Distribution Channel
- 6.3.2. Canada Catheter Related Bloodstream Infection Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Treatment Type
    - 6.3.2.2.2. By Source of Infection
    - 6.3.2.2.3. By Distribution Channel
- 6.3.3. Mexico Catheter Related Bloodstream Infection Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Treatment Type
    - 6.3.3.2.2. By Source of Infection
    - 6.3.3.2.3. By Distribution Channel

7. Europe Catheter Related Bloodstream Infection Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Treatment Type
- 7.2.2. By Source of Infection
- 7.2.3. By Distribution Channel
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Catheter Related Bloodstream Infection Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Treatment Type
    - 7.3.1.2.2. By Source of Infection
    - 7.3.1.2.3. By Distribution Channel
- 7.3.2. United Kingdom Catheter Related Bloodstream Infection Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Treatment Type
    - 7.3.2.2.2. By Source of Infection
    - 7.3.2.2.3. By Distribution Channel
- 7.3.3. Italy Catheter Related Bloodstream Infection Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Treatment Type
    - 7.3.3.2.2. By Source of Infection
    - 7.3.3.2.3. By Distribution Channel
- 7.3.4. France Catheter Related Bloodstream Infection Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Treatment Type
    - 7.3.4.2.2. By Source of Infection
    - 7.3.4.2.3. By Distribution Channel
- 7.3.5. Spain Catheter Related Bloodstream Infection Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Treatment Type
    - 7.3.5.2.2. By Source of Infection
    - 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Catheter Related Bloodstream Infection Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Treatment Type
- 8.2.2. By Source of Infection
- 8.2.3. By Distribution Channel
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Catheter Related Bloodstream Infection Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Treatment Type
    - 8.3.1.2.2. By Source of Infection
    - 8.3.1.2.3. By Distribution Channel
- 8.3.2. India Catheter Related Bloodstream Infection Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Treatment Type
    - 8.3.2.2.2. By Source of Infection
    - 8.3.2.2.3. By Distribution Channel
- 8.3.3. Japan Catheter Related Bloodstream Infection Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Treatment Type
    - 8.3.3.2.2. By Source of Infection
    - 8.3.3.2.3. By Distribution Channel
- 8.3.4. South Korea Catheter Related Bloodstream Infection Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Treatment Type
    - 8.3.4.2.2. By Source of Infection
    - 8.3.4.2.3. By Distribution Channel
- 8.3.5. Australia Catheter Related Bloodstream Infection Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Treatment Type
    - 8.3.5.2.2. By Source of Infection
    - 8.3.5.2.3. By Distribution Channel

9. South America Catheter Related Bloodstream Infection Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Treatment Type
- 9.2.2. By Source of Infection
- 9.2.3. By Distribution Channel
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Catheter Related Bloodstream Infection Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Treatment Type
    - 9.3.1.2.2. By Source of Infection
    - 9.3.1.2.3. By Distribution Channel
- 9.3.2. Argentina Catheter Related Bloodstream Infection Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Treatment Type
    - 9.3.2.2.2. By Source of Infection
    - 9.3.2.2.3. By Distribution Channel
- 9.3.3. Colombia Catheter Related Bloodstream Infection Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Treatment Type
    - 9.3.3.2.2. By Source of Infection
    - 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Catheter Related Bloodstream Infection Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Treatment Type
- 10.2.2. By Source of Infection
- 10.2.3. By Distribution Channel
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Catheter Related Bloodstream Infection Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Treatment Type
    - 10.3.1.2.2. By Source of Infection
    - 10.3.1.2.3. By Distribution Channel
- 10.3.2. Saudi Arabia Catheter Related Bloodstream Infection Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Treatment Type
    - 10.3.2.2.2. By Source of Infection
    - 10.3.2.2.3. By Distribution Channel
- 10.3.3. UAE Catheter Related Bloodstream Infection Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Treatment Type
    - 10.3.3.2.2. By Source of Infection
    - 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Teva Pharmaceutical Industries Ltd.
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. SteriMax Inc.
14.3. Sanofi S.A.
14.4. Pfizer Inc.
14.5. Novartis AG
14.6. Merck & Co., Inc.
14.7. GSK plc
14.8. Fresenius SE & Co. KGaA
14.9. Eli Lilly and Company
14.10. Aurobindo Pharma Limited